Negative symptoms and cognitive deficits in schizophrenia share many features and are
correlated in their severity on a cross-sectional basis. The question arises as to the nature of …

Neurocognitive impairment is considered a core component of schizophrenia and is
increasingly under investigation as a potential treatment target. On average, cognitive …

Objective: This study evaluated the effects of cognitive remediation for improving cognitive
performance, symptoms, and psychosocial functioning in schizophrenia. Method: A meta …

Objective: Supported employment has been shown to improve the employment outcomes of
clients with severe mental illness (SMI), but many clients who receive this service still fail to …

OBJECTIVE: Interview-based measures of cognition may serve as potential coprimary
measures in clinical trials of cognitive-enhancing drugs for schizophrenia. However, there is …

OBJECTIVES: This study examined the relationships of measures of cognitive functioning
and psychiatric symptoms with work outcomes and use of vocational services for clients with …

Neurocognitive impairment is considered a core component of schizophrenia, and is
increasingly under investigation as a potential treatment target. On average, cognitive …

Different exploratory and confirmatory factorial analyses of the Positive and Negative
Syndrome Scale (PANSS) have found a number of factors other than the original positive …

In the present study, the correspondence between clinician-assessed and self-reported
neurocognitive performance was contrasted with scores obtained from psychometric …

Insight into psychotic symptoms is typically poor in schizophrenia; however, it is not known
whether insight into neurocognitive impairment is similarly impaired. Most people with …